ScreenPoint Medical, The Breast AI Company, highlights new research from Sweden's Mammography Screening with Artificial Intelligence (MASAI) large-scale randomized controlled trial, which shows that ...
Telesurgery (operating on a patient remotely using a surgical robot via a secure telecommunication link) appears to be as ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...
First randomised controlled trial of telesurgery finds it a ‘feasible solution’ for uneven distribution of medical services.
Surgeons can safely perform two common operations from up to 2,800 kilometres away, the equivalent of a medic in southern ...
The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...
The Print on MSN
AI mammograms detect more cancers, cut later diagnoses by 12%—Swedish trial of 1 lakh women
Study involved over 1 lakh women who were randomly assigned to either AI-supported breast cancer screening or standard ...
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
Medical Device Network on MSN
Myra Vision enrols first patient in trial of Calibreye glaucoma system
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Achieving 100 enrolled patients in the NIH-funded SEANOBI Expanded-Access Program marks substantial progress in the clinical ...
Mammography supported by advanced technology results in fewer aggressive and advanced breast cancers, Lancet paper says ...
A study published in The Lancet has found that AI-supported breast cancer screening in Sweden is more effective than standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results